text.skipToContent text.skipToNavigation

Maximum quantity allowed is 999

Please select the quantity

Products > TCI Topics Archives > TCI Topics 2026 >

Highly Selective Cell-Culture-Grade GSK3 Inhibitor for iPS Cell Reprogramming and Organoid Culture

CHIR 99021 is a small-molecule inhibitor with high specificity for glycogen synthase kinase 3 (GSK-3). GSK-3 regulates multiple signaling pathways in a context-dependent manner, including glycogen and protein synthesis, cell death and survival,1) mRNA methylation,2) differentiation within the colonic secretory niche,3) and cell proliferation via the canonical Wnt pathway, through which its primary role in iPSC reprogramming is exerted. Specifically, inhibition of GSK-3 stabilizes β-catenin, resulting in activation of Wnt target genes and promotion of long-term self-renewal. Mechanistically, this involves suppression of T-cell factor 3 (Tcf3), itself a transcriptional repressor of key pluripotency factors such as Oct4, Sox2, and Nanog.4,5) Accordingly, CHIR 99021 is widely used in chemical reprogramming cocktails for iPSC generation, as well as in organoid culture systems where Wnt activation is required.
We offer two grades of CHIR 99021: a general-use grade and a cell culture grade, the latter of which has been tested for endotoxin and mycoplasma contamination for your peace of mind.

Highly Selective Cell-Culture-Grade GSK3 Inhibitor for iPS Cell Reprogramming and Organoid Culture

Related Products

C4010
CHIR 99021 [Optimized for Cell Culture]
C2943
CHIR 99021
A3679
A 83-01 [Optimized for Cell Culture]
B6661
SB 431542 [Optimized for Cell Culture]
A3324
A 83-01
B4003
SB 431542
R0224
RepSox
G0639
LY2157299

Related Products Category Pages

References

Session Status
Your session will timeout in 10 minutes. You will be redirected to the HOME page after session timeout. Please click the button to continue session from the same page. minute. You will be redirected to the HOME page after session timeout. Please click the button to continue session from the same page.

Your session has timed out. You will be redirected to the HOME page.

Switching regions will sign you out of your current session. Do you want to continue?